Interleukin-1β in Multifactorial Hypertension: Inflammation, Vascular Smooth Muscle Cell and Extracellular Matrix Remodeling, and Non-Coding RNA Regulation

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Aug 27

PMID 34445357

Citations 15

Authors

Elaina Melton

Hongyu Qiu

Affiliations

Soon will be listed here.

Abstract

The biological activities of interleukins, a group of circulating cytokines, are linked to the immuno-pathways involved in many diseases. Mounting evidence suggests that interleukin-1β (IL-1β) plays a significant role in the pathogenesis of various types of hypertension. In this review, we summarized recent findings linking IL-1β to systemic arterial hypertension, pulmonary hypertension, and gestational hypertension. We also outlined the new progress in elucidating the potential mechanisms of IL-1β in hypertension, focusing on it's regulation in inflammation, vascular smooth muscle cell function, and extracellular remodeling. In addition, we reviewed recent studies that highlight novel findings examining the function of non-coding RNAs in regulating the activity of IL-1β and its associated proteins in the setting of hypertension. The information collected in this review provides new insights into understanding the pathogenesis of hypertension and could lead to the discovery of new anti-hypertensive therapies to combat this highly prevalent disease.

Citing Articles

Renal Inflammation, Oxidative Stress, and Metabolic Abnormalities During the Initial Stages of Hypertension in Spontaneously Hypertensive Rats.

Wojtacha P, Bogdanska-Chomczyk E, Majewski M, Obremski K, Majewski M, Kozlowska A Cells. 2024; 13(21.

PMID: 39513878 PMC: 11545559. DOI: 10.3390/cells13211771.

8-Aminoguanine and its actions in the metabolic syndrome.

Jackson E, Gillespie D, Mi Z, Birder L, Tofovic S Sci Rep. 2024; 14(1):22652.

PMID: 39349636 PMC: 11442972. DOI: 10.1038/s41598-024-73159-4.

MICT ameliorates hypertensive nephropathy by inhibiting TLR4/NF-κB pathway and down-regulating NLRC4 inflammasome.

Dong W, Luo M, Li Y, Chen X, Li L, Chang Q PLoS One. 2024; 19(7):e0306137.

PMID: 39052650 PMC: 11271930. DOI: 10.1371/journal.pone.0306137.

Maresin-1 ameliorates hypertensive vascular remodeling through its receptor LGR6.

Yin Z, Zhang J, Zhao M, Peng S, Ye J, Liu J MedComm (2020). 2024; 5(3):e491.

PMID: 38463394 PMC: 10924638. DOI: 10.1002/mco2.491.

The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease.

Zhang H, Dhalla N Int J Mol Sci. 2024; 25(2).

PMID: 38256155 PMC: 10817020. DOI: 10.3390/ijms25021082.

References

Leeper N, Maegdefessel L . Non-coding RNAs: key regulators of smooth muscle cell fate in vascular disease. Cardiovasc Res. 2018; 114(4):611-621. PMC: 5852528. DOI: 10.1093/cvr/cvx249. View

Dinarello C, Arend W, Sims J, Smith D, Blumberg H, ONeill L . IL-1 family nomenclature. Nat Immunol. 2010; 11(11):973. PMC: 4174560. DOI: 10.1038/ni1110-973. View

Bui C, Kolodziej M, Lamanna E, Elgass K, Sehgal A, Rudloff I . Interleukin-1 Receptor Antagonist Protects Newborn Mice Against Pulmonary Hypertension. Front Immunol. 2019; 10:1480. PMC: 6637286. DOI: 10.3389/fimmu.2019.01480. View

Alexander M, Murgai M, Moehle C, Owens G . Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms. Physiol Genomics. 2012; 44(7):417-29. PMC: 3339851. DOI: 10.1152/physiolgenomics.00160.2011. View

Mullin C, Kato G, Ventetuolo C . Anakinra, What Is Thy Bidding in Pulmonary Hypertension?. Am J Respir Crit Care Med. 2018; 199(3):267-269. DOI: 10.1164/rccm.201811-2192ED. View

Qi H, Cao Q, Liu Q . TLR4 regulates vascular smooth muscle cell proliferation in hypertension via modulation of the NLRP3 inflammasome. Am J Transl Res. 2021; 13(1):314-325. PMC: 7847527. View

Fernandes T, Nakamuta J, Magalhaes F, Roque F, Lavini-Ramos C, Schettert I . Exercise training restores the endothelial progenitor cells number and function in hypertension: implications for angiogenesis. J Hypertens. 2012; 30(11):2133-43. DOI: 10.1097/HJH.0b013e3283588d46. View

Cruz K, de Oliveira A, Morais J, Severo J, Marreiro PhD D . Role of microRNAs on adipogenesis, chronic low-grade inflammation, and insulin resistance in obesity. Nutrition. 2017; 35:28-35. DOI: 10.1016/j.nut.2016.10.003. View

Zhuge Y, Zhang J, Qian F, Wen Z, Niu C, Xu K . Role of smooth muscle cells in Cardiovascular Disease. Int J Biol Sci. 2020; 16(14):2741-2751. PMC: 7586427. DOI: 10.7150/ijbs.49871. View

10.

Kim D, Roberts C, McKenzie A, George M . Nutritional ketosis to treat pulmonary hypertension associated with obesity and metabolic syndrome: a case report. Pulm Circ. 2021; 11(1):2045894021991426. PMC: 7894596. DOI: 10.1177/2045894021991426. View

11.

Wu N, Ye C, Zheng F, Wan G, Wu L, Chen Q . MiR155-5p Inhibits Cell Migration and Oxidative Stress in Vascular Smooth Muscle Cells of Spontaneously Hypertensive Rats. Antioxidants (Basel). 2020; 9(3). PMC: 7140008. DOI: 10.3390/antiox9030204. View

12.

Cannataro R, Caroleo M, Fazio A, La Torre C, Plastina P, Gallelli L . Ketogenic Diet and microRNAs Linked to Antioxidant Biochemical Homeostasis. Antioxidants (Basel). 2019; 8(8). PMC: 6719224. DOI: 10.3390/antiox8080269. View

13.

Cancello R, Clement K . Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG. 2006; 113(10):1141-7. DOI: 10.1111/j.1471-0528.2006.01004.x. View

14.

Polakovicova M, Musil P, Laczo E, Hamar D, Kyselovic J . Circulating MicroRNAs as Potential Biomarkers of Exercise Response. Int J Mol Sci. 2016; 17(10). PMC: 5085619. DOI: 10.3390/ijms17101553. View

15.

Villegas L, Kluck D, Field C, Oberley-Deegan R, Woods C, Yeager M . Superoxide dismutase mimetic, MnTE-2-PyP, attenuates chronic hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and activation of the NALP3 inflammasome. Antioxid Redox Signal. 2012; 18(14):1753-64. PMC: 3619229. DOI: 10.1089/ars.2012.4799. View

16.

Tuerxun D, Aierken R, Zhang Y, Huang Y, Sui S, Li X . Astragaloside IV alleviates lipopolysaccharide-induced preeclampsia-like phenotypes via suppressing the inflammatory responses. Kaohsiung J Med Sci. 2020; 37(3):236-244. DOI: 10.1002/kjm2.12313. View

17.

Zhang X, Hong S, Qi S, Liu W, Zhang X, Shi Z . NLRP3 Inflammasome Is Involved in Calcium-Sensing Receptor-Induced Aortic Remodeling in SHRs. Mediators Inflamm. 2019; 2019:6847087. PMC: 6393924. DOI: 10.1155/2019/6847087. View

18.

Kocyigit I, Taheri S, Eroglu E, Sener E, Zararsiz G, Uzun I . Systemic Succinate, Hypoxia-Inducible Factor-1 Alpha, and IL-1β Gene Expression in Autosomal Dominant Polycystic Kidney Disease with and without Hypertension. Cardiorenal Med. 2019; 9(6):370-381. DOI: 10.1159/000500478. View

19.

Kearney P, Whelton M, Reynolds K, Muntner P, Whelton P, He J . Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365(9455):217-23. DOI: 10.1016/S0140-6736(05)17741-1. View

20.

Zhou B, Qiu Y, Wu N, Chen A, Zhou H, Chen Q . FNDC5 Attenuates Oxidative Stress and NLRP3 Inflammasome Activation in Vascular Smooth Muscle Cells via Activating the AMPK-SIRT1 Signal Pathway. Oxid Med Cell Longev. 2020; 2020:6384803. PMC: 7254086. DOI: 10.1155/2020/6384803. View